Nuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb. Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN
|
|
- Andrew Carson
- 6 years ago
- Views:
Transcription
1 Nuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN VUMC PET/CT conference 2009
2 82 Rb Cardiac Perfusion PET 82 Rb is produced in a generator by decay of 82 Sr- 75 second half-life life Kinetics: Potassium analog similar to 201 Thallium High extraction fraction at high flow rates Defects visualized minutes after injection Equal doses at stress and rest due to short T½T Dose available 24 hours per day, 7 days per week Pharmacologic stress studies (no exercise)
3
4 A 75 year-old obese male with a Hx of CAD and atypical chest pain underwent dual isotope adenosine stress/rest SPECT
5 A 75 year-old obese male with a Hx of CAD and atypical chest pain underwent dual isotope adenosine stress/rest SPECT Apical ischemia, small Equivocal basal anterolateral ischemia
6 A 75 year-old obese male with a Hx of CAD and atypical chest pain Dipyridamole 82 Rb Rest 82 Rb
7 A 75 year-old obese male with a Hx of CAD and atypical chest pain Dipyridamole 82 Rb Rest 82 Rb 1) Reversible anterolateral wall perfusion defect c/w ischemia 2) Superb homogeneity
8 Stress Rest A 75 year-old obese male with a Hx of CAD and atypical chest pain SSS 9 SRS 1 SDS 8 Angiography: High-grade grade stenosis of the LCX
9 A 75 year-old obese male with a Hx of CAD and atypical chest pain Stress LVEF 41% Rest LVEF 41% Stress Rest In the absence of significant CAD, true stress EF is higher than rest EF
10 Advantages of PET compared to SPECT Higher extraction at high flow rates Better resolution than SPECT (4-6 6 mm versus 10 mm) Accurate attenuation correction methods Evaluation of ventricular function (real stress EF) Dipyridamole stress during acquisition of the images Evaluation of perfusion and metabolism Rapid perfusion imaging protocols (short half-life) life) T1/2 82 Rb: 78 sec High sensitivity instrumentation and potential for absolute quantification Measurement of coronary blood flow reserve
11 Advantage of PET Perfusion: Accurate attenuation correction! SPECT 99m Tc-MIBI stress-rest rest PET 82 Rb stress-rest rest SPECT Diaphragmatic attenuation artifact Courtesy of J. Machac-Mt Mt Sinai, NY PET with attenuation correction Normal
12 Correction for Attenuation Artifacts Attenuation effects: More significant in PET (coincidence imaging) than SPECT because both annihilation photons must pass through the region without interaction. More accurate algorithm to correct with PET than SPECT Methods: Measured attenuation correction using attenuation maps (transmission scan) obtained with various transmission sources: Sources of Ge-68 on older systems X-ray source with PET/CT
13 30 year-old obese woman with LAD dissection during pregnancy, S/P stents presented with recurrent chest pain Exercise 99m Tc- tetrafosmin no AC Rest 99m Tc- tetrafosmin Anteroseptal ischemia? Stress LVEF: 44%
14 30 year-old obese woman with LAD dissection during pregnancy, S/P stents presented with recurrent chest pain Exercise 99m Tc- tetrafosmin with AC Rest 99m Tc- tetrafosmin AC not helpful Anteroseptal ischemia? Stress LVEF: 44%
15 82 Rb PET in obese woman with prior LAD dissection Rx with PCI Equivocal SPECT and recurrent chest pain Dipyridamole 82 Rb Rest 82 Rb 82 Rb Fixed anterior wall and apex: infarct Stress LVEF: 45% Rest LVEF: 43%
16 Gated 82 Rb PET in obese woman with prior LAD dissection Rx with PCI Equivocal SPECT and recurrent chest pain Fixed anterior wall and apex: infarct Stress LVEF: 45% Rest LVEF: 43% Rest 82 Rb Stress 82 Rb
17 Characteristics of an Abnormal 82 Rb PET MPI Study with Near-Balanced Flow Reduction Either no perfusion abnormalities or more frequently a mild decrease in regional tracer uptake at peak stress in at least one coronary distribution LV cavity at peak stress larger than at rest (increased TID ratio) Peak stress LVEF < rest LVEF
18 Near-balanced perfusion 82 Rb PET Stress Rest Stress Rest Stress Rest Stress The TID ratio was In both image sets, there appears to be relatively uniform distribution of tracer On closer inspection, the entire apical segment is relatively underperfused in the peak stress images Rest Courtesy of Mid-America Heart Institute
19 PEAK STRESS LVEF 50% REST LVEF 61% In the absence of ischemia, the stress EF should be higher than the rest EF when utilizing Rb PET Courtesy of Mid-America Heart Institute
20 A 72 year-old obese female (112 kg) with known CAD s/p non Q wave MI and CABG x 4 three years earlier presented with recurrent syncope. Fixed inferolateral defect Questionable ant ischemia vs breast attenuation
21 Stress 82Rb with AC Stress 82Rb with AC
22 Stress 82Rb with AC Stress 82Rb with AC Good quality images Ischemia + infarct inferolateral wall LVEF 37% both during stress and rest Cath: LIMA to LAD: patent SVG to OM1: occluded SVG to OM2: Occluded SVG to RCA: patent
23 Advantage of PET: True stress LVEF 363 patients evaluated with 82 Rb PET Patients without prior CAD and normal perfusion: Rest LVEF: 62% +/-10% Peak stress LVEF: 67% +/- 10% --- LVEF increases at peak vasodilator stress Patients with abnormal perfusion (SSS>2) Rest LVEF: 49% +/- 15% Peak stress LVEF: 52% +/- 15% -- Patients with CAD demonstrate blunting or decrease in LVEF at peak vasodilator stress There is an inverse relationship between delta change in LVEF and magnitude of ischemia during peak vasodilator stress Dorbala S et al. J Nucl Med 2005;46:268P.
24 Advantage of PET: True stress LVEF There is an inverse relationship between delta change in LVEF and magnitude of ischemia during peak vasodilator stress LVEF change of 0 during peak vasodilator stress indicates left main or multivessel CAD Dorbala S et al. J Nucl Med 2007;
25 7% of patients with left main or 3VD (3% of MVD) have homogenous perfusion even with Rb PET Combining perfusion data with LVEF reserve permits 100% detection of balanced ischemia Dorbala S et al. J Nucl Med 2007;
26 Sensitivity/Specificity of PET for CAD Detection Study Gould (86) N 31 PET Sens 95% Spec 100% SPECT Sens - Spec - Tamaki (88) 51 98% Demer (89) % 95% - - Go (90) % 82% 79% 76% Stewart (91) 81 85% 84% 84% 53% Grover-McKay(92) % 73% - - Marwick (92) 74 90% 100% - - Bateman (06) % 93% 82% 73% Sampson (06) % 83% Average >800 90% 89%
27 Rb-82 Myocardial Perfusion Results Diagnostic Certainty: 93% Normal Prob Nl Prob Abnl Abnormal N=142 (39%) N=198 (54%) N=10 (3%) N=14 (4%) N=364 (4%) Courtesy M. Di Carli Courtesy M. Di Carli Brigham and Women s s Hospital
28 Rb-82 Myocardial Perfusion PET/CT Diagnostic Accuracy % 94% /31 16/17 Sensitivity Normalcy Courtesy M. Di Carli Brigham and Women s s Hospital
29 Sensitivity/Specificity of PET for CAD Detection Comparison Tc-MIBI SPECT (n =112)- Cardio-60 (Philips) 82 Rb PET (n = 112)- ECAT Accel (CTI) 99m Tc 82 Image Quality: SPECT: 62% PET: 78% Definitely normal or abnormal: SPECT: 81% PET: 96% PET accuracy higher: In men and women In obese and non obese patients For identification of multivessel disease For detection of stenosis > 50% and >70% Bateman T et al. J Nucl Cardiol 2006;13 (1): 24-33
30 Accuracy of PET and SPECT A. 50% coronary stenosis B. 70% coronary stenosis Bateman T et al. J Nucl Cardiol 2006;13 (1): 24-33
31 Dipyridamole Stress 82 Rb: Risk Stratification Prognostic value of 82 Rb PET MPI as a function of SSS n = ± 0.9 yrs Survival free of HE nl: mild: mod-sev sev: 0.4 % HE 2.3 % HE 7% HE Yoshinaga K et al. J Am Coll Cardiol 2006;48: Survival free of any cardiac event
32 Prognostic value of Rb PET MPI as a function of SSS in patients with equivocal SPECT Survival free of any cardiac event Yoshinaga K et al. J Am Coll Cardiol 2006;48:
33 Prognostic value of Rb PET MPI as a function of SSS in obese patients, BMI > 30 Survival free of any cardiac event Yoshinaga K et al. J Am Coll Cardiol 2006;48:
34 Dipyridamole Stress 82 Rb: Risk Stratification 1,602 patients with median follow-up of 511 days Incremental value of stress perfusion defect over clinical variables in predicting overall survival. 1,274 patients with median follow-up of 511 days Incremental value of LVEF over stress perfusion imaging. Dorbala S et al. J Am Coll cardiol 2007;49:109A
35 Radiation Dose from Cardiovascular Imaging Tc-MIBI (30 mci): ~10 msv (1000 mrem) Tl (3.5 mci): ~20 msv (2,000 mrem) Rb (120 mci) or : 3-15 msv (according to model)# 5 msv (200 mrem)* N-ammonia (40 mci): 2 msv (220 mrem) F-FDG FDG (10 mci): 7 msv (600 mrem) CT Attenuation correction: 0.8 msv ( mrem) CT chest: 4-6 msv ( mrem) CACS (prospective gating): msv ( mrem) CTA (retrospective gating): 8-12 msv ( mrem) With dose reduction: 3-5 msv Catheter angiography 3-12 msv Morin RL, et al. Circulation. 2003;107: Budoff MJ, et al. J Am Coll Cardiol. 2003;42: Thompson RC et al. J Nucl Cardiol 2006;13: #Stabin MG. J Nucl Med 2008;49: * Package insert
36 Why Should We Do 82 Rb Cardiac PET? It is more accurate for detection of CAD It has a higher normalcy rate It has a higher diagnostic certainty It has a high prognostic value It s s safer For the patient For the technologist It is faster
37 82 Rb rest/stress PET/CT Protocol Rb mci Dipy 0.56 mg/kg Rb mci scout CT-trans sec sec gated rest pt out scout sec sec gated stress CT-trans Approx 1 min Approx 7 min Approx 6 min Approx 7 min Approx 1 min Gated rest/stress MP study is completed in approximately 30 mins Courtesy of M. Di Carli, Brigham and Women Hospital
38 CardioGen-82 Generator replaced every 28 days $29,000/month Generator must be utilized with the calibrated CardioGen-82 Infusion System (Start-up cost of $72,000) Infusion System is automated for the infusion and patient dose Permits accurate dosing with minimal operator interface, thus decreasing radiation exposure Contains shielding vault for CardioGen-82 Generator and waste container
39 82 Rb Cardiac PET Acquisition Times Fraction min 80% 95% Fraction of Activity Remaining Fraction of Counts Rec iev ed to Total Pos sible Fraction of counts to be gained by acquiring for 60 Additional Seconds Seconds into Scan Acquisition times need to recognize fast decay of 82 Rb 95% of theoretical max cts will be acquired in first 5 minutes (80% in first 3 minutes) Acquiring an additional 1 min only adds 2.4% more cts
40 In patients with reduced LV function, crucial to wait sufficiently for blood pool to clear to avoid scatter into perfusion defects leading to erroneous diagnosis of ischemia
41 SNM/ASNC : 82 Rb Rest/stress Guidelines Infusion rate 1 ml/s, 30 sec. Max Imaging delay after infusion (LVEF>50%) s Imaging delay after infusion LVEF<50% s. Longer if counts permit. Phased acquisitions (rapid, sequential imaging) can be used to compensate for slow blood pool clear Machac J et al et al. Guidelines J Nucl Cardiol 2006;13 (6):e ),
42 Quality Control for accuracy of co-registration!
43 Middle age female with an equivocal outside stress/rest SPECT Adenosine 13NH3 Rest 13NH 3 Artifactual stress anterolateral defect due to mis-registration
44 Potential Limitations of PET Limited availability of PET Costly initial capital investment Limitation to pharmacological stress Lack of accepted guidelines for indications (PET versus SPECT) Indications accepted now: All pharmacological stress if PET available Obese patients who can not exercise Lack of standardized software for analysis Now: ECTtoolbox: : normal database for 82 Rb and 13 N- ammonia Limited practical capabilities for absolute quantification: Requires dynamic imaging Requires kinetic analysis and compartmental modeling
45 Cardiac PET Conclusions Myocardial PET perfusion High normalcy rate (accurate attenuation correction) High accuracy for detection of CAD Including multi-vessel disease (True LV EF, TID) High diagnostic certainty High prognostic value Indications Same as SPECT Well accepted: Obese ( > 250 lb?) who can not exercise Patients difficult to image by SPECT: Obese, women, children Contradictory or equivocal previous studies Myocardial viability: Perfusion PET/FDG PET
46 Thank you!
Conflict of Interest Disclosure
Comparative Advantages of PET Over SPECT: Is PET Really Better? Timothy M. Bateman M.D. Co-Director, Cardiovascular Radiologic Imaging Mid America Heart Institute Professor of Medicine University of Missouri-Kansas
More informationCARDIAC PET PERFUSION IMAGING with RUBIDIUM-82
CARDIAC PET PERFUSION IMAGING with RUBIDIUM-82 Pr Denis AGOSTINI Président du Groupe de Cardiologie Nucléaire et IRM CHU Caen Bordeaux 2006 Cardiac Perfusion-Metabolism Mismatch with PET Cumulative Survival
More informationNUCLEAR CARDIOLOGY UPDATE
Nuclear Cardiology David K. Shelton, Jr., MD NUCLEAR CARDIOLOGY UPDATE No Conflicts. No Disclosures. No Smoking. David K. Shelton UCDMC Nuclear Cardiology Nuclear Cardiology Radionuclide Ventriculography
More informationPearls & Pitfalls in nuclear cardiology
Pearls & Pitfalls in nuclear cardiology Maythinee Chantadisai, MD., NM physician Division of Nuclear Medicine, Department of radiology, KCMH Principle of myocardial perfusion imaging (MPI) Radiotracer
More informationMyocardial Perfusion: Positron Emission Tomography
Myocardial Perfusion: Positron Emission Tomography TH. Schindler, MD University Hospitals of Geneva, Cardiovascular Center, Geneva, Switzerland ESC 2010 Stockholm Personal Disclosure Research Grant support
More informationUse of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users
Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users February 1 5, 2011 University of Santo Tomas Hospital Angelo King A-V Auditorium Manila,
More informationAbnormal, Autoquant Adenosine Myocardial Perfusion Heart Imaging. ID: GOLD Date: Age: 46 Sex: M John Doe Phone (310)
Background: Reason: preoperative assessment of CAD, Shortness of Breath Symptom: atypical chest pain Risk factors: hypertension Under influence: a beta blocker Medications: digoxin Height: 66 in. Weight:
More informationPreview of Presentation
Preview of Presentation Discuss Healthcare Environment Clinical Implementation of Technical Innovations SNMMI/ASNC Joint Statement on Rb-82 Cardiac PET Imaging Protocol Principles of Rb-82 Cardiac Imaging
More informationConflict of Interest Disclosure
Challenges and Opportunities for SPECT & PET in 2013: Implementing Latest Acquisition and Processing Protocols Timothy M. Bateman M.D. Co-Director, Cardiovascular Radiologic Imaging Mid America Heart Institute
More informationThe Role of Nuclear Imaging in Heart Failure
The Role of Nuclear Imaging in Heart Failure Mouaz H. Al-Mallah, MD MSc FESC Associate Professor of Medicine Consultant Cardiologist and Division Head, Cardiac Imaging King Abdulaziz Cardiac Centre, National
More informationSPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin
SPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin Elmer Jasper B. Llanes, M.D. Nuclear Cardiology St. Luke s Medical Center Outline Ideal Physiologic Characteristics of MPI radioactive tracers
More informationPrevious MI with no intervention
Previous MI with no intervention F. Mut, M. Beretta Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Clinical history Woman 68 y.o. Recent acute MI (3 weeks) with no intervention. Discharged
More informationPET for the Evaluation of Myocardial Viability
PET for the Evaluation of Myocardial Viability Myocardial viability assessment is an important part of cardiac PET to assist physicians to decide upon the best surgical or medical procedures. F-18 FDG
More informationSPECT or PET for Cardiovascular Screening in High-Risk Patients
SPECT or PET for Cardiovascular Screening in High-Risk Patients Paeng, Jin Chul MD PhD Department of Nuclear Medicine Seoul National University Hospital Contents Recent Development in SPECT and PET Technology
More informationAdvantages of PET Myocardial Imaging
Advantages of PET Myocardial Imaging Legal Disclaimers These materials were prepared in good faith by MITA as a service to the profession and are believed to be reliable based on current scientific literature.
More informationCase-Based Pitfalls of SPECT and PET: Recognizing and Working with Artifacts
2:20 PM Friday WORKSHOP V Case-Based Pitfalls of SPECT and PET: Recognizing and Working with Artifacts Sean W. Hayes, MD Associate Clinical Professor of Medicine UCLA School of Medicine Cedars-Sinai Heart
More informationStress only Perfusion Imaging
European Society of Cardiology Annual meeting, 2010, Stockholm, Sweden Stress only Perfusion Imaging Oliver Gaemperli, MD Cardiovascular Center, University Hospital Zurich, Switzerland Male patient, 48
More informationFundamentals of Nuclear Cardiology. Terrence Ruddy, MD, FRCPC, FACC
Fundamentals of Nuclear Cardiology Terrence Ruddy, MD, FRCPC, FACC Objectives To understand the Principles of Nuclear Cardiac Imaging Radiotracers Image acquisition and processing Stress protocols To appreciate
More informationUpdate in Nuclear Cardiology: Patient-Centered Imaging Radiation Dose Reduction
Update in Nuclear Cardiology: Patient-Centered Imaging Radiation Dose Reduction E. Gordon DePuey, M.D. Icahn School of Medicine ant Mt. Sinai New York, NY Disclosures: Grant Support: Michael J. Fox Foundation
More informationHigh Speed Myocardial Perfusion SPECT: Validation of Quantitative Analysis and use in Low Dose Stress only Protocol
High Speed Myocardial Perfusion SPECT: Validation of Quantitative Analysis and use in Low Dose Stress only Protocol Tali Sharir 1, Marina Pinskiy 1, Vitaly Prochorov 1, Andrzej Bojko 1, Arik Rochman 1,
More informationCHRONIC CAD DIAGNOSIS
CHRONIC CAD DIAGNOSIS Chest Pain Evaluation 1. Approach to diagnosis of CAD 2. Classification of chest pain 3. Pre-test likelihood CAD 4. Algorithm for chest pain evaluation in women 5. Indications for
More informationNew Challenges in Nuclear Cardiology Practice
New Challenges in Nuclear Cardiology Practice Brian G. Abbott, MD, FACC, FASNC, FAHA President, ASNC 2016 Associate Professor of Medicine Warren Alpert Medical School of Brown University Director, Cardiovascular
More information1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and
1 The clinical syndrome of heart failure in adults is commonly associated with the etiologies of ischemic and non-ischemic dilated cardiomyopathy, hypertrophic cardiomyopathy, hypertensive heart disease,
More informationMyocardial blood flow PET evaluation and quantification. Dr. Erick Alexánderson. Rosas
Myocardial blood flow PET evaluation and quantification Dr. Erick Alexánderson Rosas Clinical case 62 year old female patient with a history of DM2 and chronic systemic hypertension She complains of progressive
More informationValidation of CT Perfusion Imaging Against Invasive Angiography and FFR on a 320-MDCT Scanner
Validation of CT Perfusion Imaging Against Invasive Angiography and FFR on a 320-MDCT Scanner Zhen Qian, Gustavo Vasquez, Sarah Rinehart, Parag Joshi, Eric Krivitsky, Anna Kalynych, Dimitri Karmpaliotis,
More informationNuclear Perfusion Imaging of Angina
January 2002 Nuclear Perfusion Imaging of Angina Davin Quinn HMS III Beth Israel Deaconess Medical Center Radiology Department Goals of Presentation Understand what a perfusion scan is Understand what
More informationMyocardial Perfusion SPECT How to do it E. Moralidis
Myocardial Perfusion SPECT How to do it E. Moralidis Aristotelian University AHEPA Hospital Thessaloniki Myocardial perfusion SPECT procedure Stress Imaging Data analysis and reporting Myocardial perfusion
More informationRADIOTRACERS FOR MYOCARDIAL PERFUSION IMAGING
RADIOTRACERS FOR MYOCARDIAL PERFUSION IMAGING RAYMOND TAILLEFER, M.D. FRCP(c), ABNM DIRECTOR, DEPARTMENT OF NUCLEAR MEDICINE HOPITAL ST-JEAN-SUR-RICHELIEU Disclosures to Report: Grant Research Support:
More informationHybrid Imaging Improving Nuclear Cardiology Practice
Lippincott Williams & Wilkins, - Nuclear Medicine teaching File, 2009 Hybrid Imaging Improving Nuclear Cardiology Practice João V. Vitola, MD, PhD Cardiologist and Nuclear Medicine Physician Quanta Diagnostico
More informationOTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.
DEFINITION OF CARDIAC RADIOPHARMACEUTICAL: A radioactive drug which, when administered for purpose of diagnosis of heart disease, typically elicits no physiological response from the patient. Even though
More informationAtypical pain and normal exercise test
Atypical pain and normal exercise test F. Mut, M. Beretta Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Clinical history 67-year old male with several coronary risk factors. Atypical
More informationJe bénéficie régulièrement de fonds privés, dans le cadre de projets de recherche ou d activités de formation.
Je bénéficie régulièrement de fonds privés, dans le cadre de projets de recherche ou d activités de formation. Ces fonds proviennent essentiellement d industriels travaillant dans les domaines de l imagerie
More informationSPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος
SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος Δρ Αναστασία Κίτσιου Διευθύντρια, Καρδιολογική Κλινική, Σισμανόγλειο ΓΝΑ Chair, Education Committee, Section on Nuclear Cardiology & Cardiac CT, EACVI, ESC
More informationCurrent Tracers. João V. Vitola, MD, PhD. Cardiologist and Nuclear Medicine Physician Quanta Diagnostico Nuclear Curitiba - Brazil
Current Tracers João V. Vitola, MD, PhD Cardiologist and Nuclear Medicine Physician Quanta Diagnostico Nuclear Curitiba - Brazil SPECT - Tracer Characteristics TC-99m tracers and protocols One or two day
More information2017 Qualified Clinical Data Registry (QCDR) Performance Measures
2017 Qualified Clinical Data Registry (QCDR) Performance Measures Description: This document contains the 15 performance measures that were approved by CMS for use in ASC's 2017 Qualified Clinical Data
More informationPET myocard perfusion & viability Riemer Slart
PET myocard perfusion & viability Riemer Slart Nuclear Medicine Physician Dept. of Nuclear Medicine and Molecular Imaging University Medical Center Groningen, the Netherlands Professor in Molecular Imaging,
More informationParadoxical pattern in a patient with previous myocardial infarction F. Mut, M. Kapitan
Paradoxical pattern in a patient with previous myocardial infarction F. Mut, M. Kapitan Nuclear Medicine Service, Italian Hospital Montevideo, Uruguay Clinical history Woman 66 y.o. Previous MI. Dyspnea
More informationHybrid imaging of the heart
Pärnu (Estonia) Friday, October 10, 2014 8:00-8:30 a.m Hybrid imaging of the heart María José García Velloso Servicio de Medicina Nuclear Clínica Universidad de Navarra mjgarciave@unav.es Hibrid imaging
More informationCardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute
Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute 62 year old male Anterior STEMI late presentation, occluded
More informationTechnical Meeting on: Current Role of Nuclear Cardiology in the Management of Cardiac Diseases Vienna, May 2008 Vienna International Centre
Technical Meeting on: Current Role of Nuclear Cardiology in the Management of Cardiac Diseases Vienna, 5-95 9 May 2008 Vienna International Centre Evidence-based Nuclear Cardiology: Imaging of CAD The
More informationEvaluation of Myocardial Viability: What Have We Learned from STICH? Professor of Medicine David Geffen School of Medicine at UCLA. Heart Failure (HF)
Evaluation of Myocardial Viability: What Have We Learned from STICH? Daniel S. Berman, MD Director, Cardiac Imaging Cedars-Sinai Heart Institute CSMC 2013 Professor of Medicine David Geffen School of Medicine
More informationCardiac PET. John Buscombe
Cardiac PET John Buscombe Why PET? Improved resolution-not really required in cardiology Improved sensitivity this may be important-financially as reduced acquisition time Improved attenuation correction-good
More informationPositron emission tomography and molecular imaging
Positron emission tomography and molecular imaging EHH, May, 2010 Juhani Knuuti Turku PET Centre University of Turku Turku, Finland Juhani.knuuti@utu.fi PET Imaging in Medicine MRI CT MRI PET US SPET MEG
More informationASNC CONSENSUS STATEMENT REPORTING OF RADIONUCLIDE MYOCARDIAL PERFUSION IMAGING STUDIES. Approved August 2003
ASNC CONSENSUS STATEMENT REPORTING OF RADIONUCLIDE MYOCARDIAL PERFUSION IMAGING STUDIES Approved August 2003 Robert C. Hendel, M.D. Frans J. Th. Wackers, M.D., Ph.D. Daniel S. Berman, M.D. Edward Ficaro,
More informationFFR-Guided PCI. 4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea. Stanford
4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea FFR-Guided PCI William F. Fearon, M.D. Associate Professor Division of Cardiovascular Medicine University Medical Center Disclosure Statement
More informationPatient-centered Imaging in Coronary Artery Disease. Jason H Cole, MD, MS, FACC January 10, 2015
Patient-centered Imaging in Coronary Artery Disease Jason H Cole, MD, MS, FACC January 10, 2015 Non-invasive coronary imaging Non-invasive cardiac imaging has improved assessment of cardiac function, anatomy,
More informationFractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center
Fractional Flow Reserve: Basics, FAME 1, FAME 2 William F. Fearon, MD Associate Professor Stanford University Medical Center Conflict of Interest Advisory Board for HeartFlow Research grant from St. Jude
More information2019 Qualified Clinical Data Registry (QCDR) Performance Measures
2019 Qualified Clinical Data Registry (QCDR) Performance Measures Description: This document contains the 18 performance measures approved by CMS for inclusion in the 2019 Qualified Clinical Data Registry
More informationPET MYOCARDIAL PERFUSION AND QUANTIFICATION OF FLOW
PET MYOCARDIAL PERFUSION AND QUANTIFICATION OF FLOW Robert Bober, MD, FACC Director of Nuclear Cardiology and Molecular Imaging John Ochsner Heart and Vascular Institute The Ochsner Clinical School University
More informationINTRAVENOUS ADENOSINE MYOCARDIAL PERFUSION STUDY (rest/pharmacologic stress SPECT with gated SPECT wall motion studies at rest and post-stress)
nucware.com, LLC Product Demo Anytown Cardiac Specialists, Inc. Janet Jones, MD, FACC Ed Wilson, MD, FACC Tom Smith, MD, FACC Jim Wilson, MD, FACC John Womack, MD, FACC JOHNSON, VICTOR DOB: 09/06/1938
More informationRole of Myocardial Perfusion Imaging in the Cardiac Evaluation of Aviators
Original Research Role of Myocardial Perfusion Imaging in the Cardiac Evaluation of Aviators Anil Kumar AVS *, Kumar PG +, Prakash MS # ABSTRACT In an attempt to provide more accurate and inclusive information
More informationRational use of imaging for viability evaluation
EUROECHO and other imaging modalities 2011 Rational use of imaging for viability evaluation Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology, CHU Liège, Belgium
More informationI have no financial disclosures
Manpreet Singh MD I have no financial disclosures Exercise Treadmill Bicycle Functional capacity assessment Well validated prognostic value Ischemic assessment ECG changes ST segments Arrhythmias Hemodynamic
More informationCombining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging
Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging Daniel S. Berman, MD Director, Cardiac Imaging Cedars-Sinai Heart Institute Professor of Medicine and Imaging Cedars-Sinai
More informationDual Energy CT of the Heart: Perfusion and Beyond
Dual Energy CT of the Heart: Perfusion and Beyond U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging Disclosures Consultant
More informationMyocardial viability testing. What we knew and what is new
Myocardial viability testing. What we knew and what is new Dr B K S Sastry, MD, DM. CARE Hospitals, Hyderabad What is Viability Viability Dysfunctional myocardium subtended by diseased coronary arteries
More informationA Snapshot on Nuclear Cardiac Imaging
Editorial A Snapshot on Nuclear Cardiac Imaging Khalil, M. Department of Physics, Faculty of Science, Helwan University. There is no doubt that nuclear medicine scanning devices are essential tool in the
More informationJ. Schwitter, MD, FESC Section of Cardiology
J. Schwitter, MD, FESC Section of Cardiology CMR Center of the CHUV University Hospital Lausanne - CHUV Switzerland Centre de RM Cardiaque J. Schwitter, MD, FESC Section of Cardiology CMR Center of the
More informationCT or PET/CT for coronary artery disease
CT or PET/CT for coronary artery disease Rotterdam 2012 Juhani Knuuti, MD, PhD, FESC Turku PET Centre University of Turku Turku, Finland Juhani.knuuti@utu.fi Turku PET Centre University of Turku Åbo Akademi
More information@02-126_Coronary_calcification.ppt. Professor Molecular and Medical Pharmacology
Assessment of Myocardial Viability Jamshid Maddahi, M.D., FACC, FASNC Professor Molecular and Medical Pharmacology (Nuclear Medicine) and Medicine (Cardiology) David Geffen School of Medicine at UCLA Director,
More informationImaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD
Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference
More informationPET MPI Limitations of SPECT MPI
Recent Advances in uclear Cardiology The Impact of PET Myocardial Perfusion Imaging and ew Pharmacologic Agents SPECT MPI (Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging) Widely
More informationWhich Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute
Which Test When? Avoid the Stress of Stress Testing Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute Outline Understand the importance of coronary artery disease assessment Understand the basics
More informationDisclosure Information
Coronary CTA Pearls and Pitfalls Ricardo C. Cury, MD, FSCCT, FAHA, FACC Chairman of Radiology Radiology Associates of South Florida Director of Cardiac Imaging Miami Cardiac and Vascular Institute Past-President
More informationmsv Stress dose (mci) Stress dose (MBq)
Supplemental Table 1. A Sample Weight Based Dosing for 99m Tc Sestamibi MPI Using a Dedicated Cardiac SPECT Scanner Weight range Rest (mci) Rest (MBq) msv Stress (mci) Stress (MBq) msv Total msv (rest
More informationTypical chest pain with normal ECG
Typical chest pain with normal ECG F. Mut, C. Bentancourt, M. Beretta Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Clinical history Male 41 y.o. Overweight, hypertension, high cholesterol,
More informationWelcome! To submit questions during the presentation: or Text:
Welcome! To participate in the interactive Q & A please do the following: 1. Download the Socrative Student App 2. Enter Teacher s Room Code: ZD0F3X5Q 3. Select Quiz: Intermountain Cardiac Stress Testing
More informationCan Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!
Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Young-Hak Kim, MD, PhD Heart Institute, University of Ulsan College of Medicine Asan Medical Center,
More informationTypical PET Image. Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located?
Typical PET Image Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located? PET/CT Oncology Imaging Anatometabolic fusion images are useful in the management
More informationCONFUSION IN CARDIAC TESTING. Bilal Aijaz M.D FACC FSCAI
CONFUSION IN CARDIAC TESTING Bilal Aijaz M.D FACC FSCAI WHY DOES CARDIOLOGY HAVE SO MANY TESTS? to create confusion (of course) to generate more business (maybe?) to accommodate the ever expanding patient
More informationPhoton Attenuation Correction in Misregistered Cardiac PET/CT
Photon Attenuation Correction in Misregistered Cardiac PET/CT A. Martinez-Möller 1,2, N. Navab 2, M. Schwaiger 1, S. G. Nekolla 1 1 Nuklearmedizinische Klinik der TU München 2 Computer Assisted Medical
More informationRadiologic Assessment of Myocardial Viability
November 2001 Radiologic Assessment of Myocardial Viability Joshua Moss, Harvard Medical School Year III Patient EF 66yo female with a 3-year history of intermittent chest pain previously relieved by sublingual
More informationCardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?
Keenan Research Centre Li Ka Shing Knowledge Institute Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures? Howard Leong-Poi, MD, FRCPC Associate Professor of Medicine St.
More informationMINIMIZING RADIATION EXPOSURE
MINIMIZING RADIATION EXPOSURE FROM MYOCARDIAL PERFUSION IMAGING ASNC 2017 Choosing Wisely Challenge Debra Mahlum, Maureen Vander Kooy, Steven Port, M.D. Aurora Cardiovascular Services Disclosure Information
More informationNuclear Cardiology Pierre-Yves MARIE Department of Nuclear Medicine CHU-Nancy, FRANCE.
Nuclear Cardiology Pierre-Yves MARIE Department of Nuclear Medicine CHU-Nancy, FRANCE. Nuclear Cardiology I - A remaining need of a functional information on myocardial perfusion II - The future: - combining
More informationDiagnostic and Prognostic Value of Coronary Ca Score
Diagnostic and Prognostic Value of Coronary Ca Score Dr. Ghormallah Alzahrani Cardiac imaging division, Adult Cardiology department Prince Sultan Cardiac Center ( PSCC) Madina, June 2 Coronary Calcium
More informationORIGINAL ARTICLE. Diagnostic accuracy of high-resolution attenuation-corrected Anger-camera SPECT in the detection of coronary artery disease
ORIGINAL ARTICLE Diagnostic accuracy of high-resolution attenuation-corrected Anger-camera SPECT in the detection of coronary artery disease Harshal R. Patil, MD, a,b,d Timothy M. Bateman, MD, a,b,c,d
More informationHybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future
Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future Prof. Juhani Knuuti, MD, FESC Turku, Finland Disclosure: Juhani Knuuti, M.D. Juhani Knuuti, M.D. has financial
More informationSung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center
CMR Perfusion and Viability A STICH Out of Time? Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center Can Imaging Improve
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Clinica Cardiologica Università degli Studi di Padova Direttore: Prof. Sabino Iliceto BENEFITS OF REAL-TIME 3D STRESS ECHOCARDIOGRAPHY Luigi P. Badano**, MD, FESC **Dr.
More informationCardiac Diagnostics Workshop. Lori Savard NP Cardiology Update 2015
Cardiac Diagnostics Workshop Lori Savard NP Cardiology Update 2015 Disclosure of Commercial Support Potential for conflict(s) of interest: none Objectives Increase understanding regarding stable IHD and
More informationHospital, 6 Lukon Road, Lukong Town, Changhua Shien, Taiwan 505, Taiwan.
Volume 1, Issue 1 Image Article Resolution of Inferior Wall Ischemia after Successful Revascularization of LAD Lesion: The Value of Myocardial Perfusion Imaging in Guiding Management of Multi-vessel CAD
More informationEvaluating Clinical Risk and Guiding management with SPECT Imaging
Evaluating Clinical Risk and Guiding management with SPECT Imaging Raffaele Giubbini Chair and Nuclear Medicine Unit University & Spedali Civili Brescia- Italy U.S. Congressional Budget Office. Technological
More informationCASE from South Korea
CASE from South Korea Bon-Kwon Koo, MD, PhD, Seoul, Korea Outpatient clinic of a non-interventional cardiologist F/56 Chief complaint: Angina with recent aggravation, CCS II~III Brief history: # Stroke
More informationORIGINAL ARTICLE. Iulia Heinle 1,*, Andre Conradie 2 and Frank Heinle 1
PJNM 2011, 1:42-48 331691 2011 Pakistan Society of Nuclear Medicine ORIGINAL ARTICLE A clinical and angiographic correlation of myocardial perfusion scintigraphy in the assessment of isolated apical/peri-apical
More informationFractional Flow Reserve and the Results of the FAME Study
Imaging and Physiology Summit Seoul, Korea November 21 st, 2009 Fractional Flow Reserve and the Results of the FAME Study William F. Fearon, M.D. Assistant Professor Division of Cardiovascular Medicine
More informationCardiac Imaging. Kimberly Delcour, DO, FACC. Mahi Ashwath, MD, FACC, FASE. Director, Cardiac CT. Director, Cardiac MRI
Cardiac Imaging Kimberly Delcour, DO, FACC Director, Cardiac CT Mahi Ashwath, MD, FACC, FASE Director, Cardiac MRI Cardiac Imaging Discuss the clinical applications of and indications for: Cardiac CT Nuclear
More informationStable Angina: Indication for revascularization and best medical therapy
Stable Angina: Indication for revascularization and best medical therapy Cardiology Basics and Updated Guideline 2018 Chang-Hwan Yoon, MD/PhD Cardiovascular Center, Department of Internal Medicine Bundang
More informationEmerging role of PET in nuclear cardiology. Dr. Erick Alexánderson. Rosas
Emerging role of PET in nuclear cardiology Dr. Erick Alexánderson Rosas PET principles e + e - 180 PET/CT Cyclotron Unit UNAM Cyclotron Radiopharmacy PET Camera CT PET PET CT Perfusion Anatomic evaluation
More informationJournal of the American College of Cardiology Vol. 49, No. 10, by the American College of Cardiology Foundation ISSN /07/$32.
Journal of the American College of Cardiology Vol. 49, No. 10, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.12.015
More informationCurrent and Future Imaging Trends in Risk Stratification for CAD
Current and Future Imaging Trends in Risk Stratification for CAD Brian P. Griffin, MD FACC Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Disclosures: None Introduction
More informationTesting the Asymptomatic CAD Patient: When and Why?
Testing the Asymptomatic CAD Patient: When and Why? Timothy M. Bateman M.D. Co-Director, Cardiovascular Radiologic Imaging Mid America Heart Institute Professor of Medicine University of Missouri-Kansas
More information海外研究留学報告 福島賢慈 東京女子医科大学 画像診断 核医学部 核医学地方会 2011 Jan
2011 Jan Maryland state (MD), USA Maryland state (MD), USA Baltimore city, MD Baltimore city, MD Myocardial Perfusion PET tracers PET Tracers Half life Production First Pass Extraction Kinetic Properties
More informationThe 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D.
The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum David C. Levin, M.D. October 16, 2016 MPI Utilization Rates/1000[includes PET] total radiologists 2014 total
More informationGetting the Most Out of Stress Echo
Getting the Most Out of Stress Echo Vera H. Rigolin, MD, FASE, FACC, FAHA Professor of Medicine Northwestern University Feinberg School of Medicine Medical Director, Echocardiography Laboratory Northwestern
More informationFellows on this rotation are expected to attend nuclear conferences and multimodality imaging conference.
Rotation: Imaging 1 Imaging 1 provides COCATS Level 1 experience for nuclear cardiology (including SPECT and PET) and cardiac CT. Fellows will administer, process, and read cardiac nuclear studies with
More informationNuclear medicine in general practice. Dr Reza Garzan MD, FRACP, FAANMS
Nuclear medicine in general practice Dr Reza Garzan MD, FRACP, FAANMS Myocardial perfusion study Bone scans in general practice Thyroid scans in general practice Gamma camera Detection of gamma rays Myocardial
More informationRecent Advances in Clinical Nuclear Cardiology and Cardiac CT: State-of-the-Art Updates and 101 Evidence-Based Case Reviews
AGENDA Wednesday, May 9 4:00 p.m. 6:00 p.m. Registration Thursday, May 10 7:00 a.m. Registration and Continental Breakfast 7:45 a.m. Course Overview and Objectives Session #1: Advances in SPECT and PET
More informationMultisclice CT in combination with functional imaging for CAD. Temporal Resolution. Spatial Resolution. Temporal resolution = ½ of the rotation time
Multisclice CT in combination with functional imaging for CAD Prof. Juhani Knuuti, MD, FESC Turku University Hospital and University of Turku Turku, Finland MSCT and functional imaging for CAD Practical
More informationNuclear Cardiology Reimbursement. Todd Lamb, BS, AS, CNMT Clinical Operations Mgr Regions Hospital St. Paul, MN
Nuclear Cardiology Reimbursement Todd Lamb, BS, AS, CNMT Clinical Operations Mgr Regions Hospital St. Paul, MN Slides are not to be reproduced without the permission of the author Slides are not to be
More information